AzTrials
AzTrials

FeedingMetChronoNCT07122765

Effect of Caloric Content and Timing of Meal on Postprandial Substrate Oxidation and Pulse Wave Analysis

A study testing Mixed Meal Feeding Challenge in people with Feeding and Metabolism, run by George Washington University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overarching aim of this research is to study the effects of caloric content and timing of meals on measures of postprandial metabolism and cardiovascular response 1. Determine the effect of caloric content on measures of postprandial metabolic flexibility and pulse wave analysis to a mixed meal challenge. 2. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Feeding, Metabolism, Indirect Calorimetry
What is being tested?
Mixed Meal Feeding Challenge
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
3 Nov 2024to 15 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Males or Females between the ages of 18 and 45 years
  • Low risk for medical complications as determined by physical activity readiness questionnaire (PARQ).
  • Not currently taking antioxidant supplementation, non-steroidal anti-inflammatory drugs (NSAIDS) in a prescribed manner, antibiotics, steroids, or probiotics.
  • Not currently taking any medications for management of cholesterol, diabetes, or body weight/obesity, or are undergoing transgender hormone therapy.
  • Not currently pregnant
  • No history of disordered eating, including anorexia nervosa, bulimia nervosa, binge eating disorder, or avoidant restrictive food intake disorder or screened as high risk for disordered eating via validated questionnaire.
Show all 9Show fewer
  • No history of gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome, Celiac disease, Crohn's disease, or lactose intolerance.
  • Considered low risk for food insecurity via the Hunger Vital Sign screener.
  • Cannot have followed a ketogenic diet within the last three months or have been told to avoid a high-fat diet by a medical provider due to cardiovascular disease risk.

Who cannot join

  • Are currently taking any antioxidant supplementation (daily multivitamin not included), prescribed non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, steroids, or probiotics.
  • Are currently taking any medications for management of cholesterol, diabetes, or body weight/obesity, or are undergoing hormone therapy (oral contraceptives not included).
  • Are unwilling or unable to comply with study procedures, at the discretion of the investigators.
  • Pregnant women - A urine pregnancy test will be conducted prior to any testing procedures.
  • A history of disordered eating, including anorexia nervosa, bulimia nervosa, binge eating disorder, or avoidant restrictive food intake disorder or deemed high-risk for disordered eating via questionnaire.
  • A history of gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), Celiac disease, Crohn's disease, or lactose intolerance.
  • Deemed high risk for food insecurity via the Hunger Vital Sign screener which is filled out electronically prior to enrollment.
  • Have followed a ketogenic diet within the last three months or have been told to avoid a high-fat diet by a medical provider for risk of cardiovascular disease.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • George Washington University School of Public Health

    Washington D.C., District of Columbia, 20052

Other trials in United States

About this study

Official title: Effect of Caloric Content And Timing of Meal On Postprandial Substrate Oxidation And Pulse Wave Analysis

The overarching aim of this research is to study the effects of caloric content and timing of meals on measures of postprandial metabolism and cardiovascular response

  1. Determine the effect of caloric content on measures of postprandial metabolic flexibility and pulse wave analysis to a mixed meal challenge.
  2. Determine the effect of meal timing on measures of postprandial metabolic flexibility and pulse wave analysis to a mixed meal challenge.

Hypothesis: 1) that hypercaloric meals will result in significantly reduced indices of metabolic flexibility and pulse wave analysis as compared to eucaloric meals and 2) eucaloric meals consumed later in the day will result in significantly reduced metabolic flexibility and pulse wave analysis as compared to eucaloric meals consumed in the morning.

Being tested
Mixed Meal Feeding Challenge
Keywords
Feeding, postprandial, metabolism, pulse wave analysis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mixed Meal Feeding ChallengeOther

    Liquid flavored Ensure Plus Shake of varying caloric content based on individual daily estimated caloric need

Study groups in NCT07122765
Study groupRoleWhat they receive
Eucaloric Morning Mixed Meal ChallengeActive comparatorMorning Mixed Meal Challenge (Liquid Shake), 25% of estimated daily caloric need
Receives: Other: Mixed Meal Feeding Challenge
Eucaloric Evening Mixed Meal ChallengeExperimentalEvening Mixed Meal Challenge (Liquid Shake), 25% of estimated daily caloric need
Receives: Other: Mixed Meal Feeding Challenge
Hypercaloric Morning Mixed Meal ChallengeExperimentalMorning Mixed Meal Challenge (Liquid Shake), 37.5% of estimated daily caloric need
Receives: Other: Mixed Meal Feeding Challenge

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pulse Wave Analysis

    Augmentation Index normalized to 75 beats per minute as index of pulse wave reflection

    Measured: Baseline to 60 and 120 minutes postprandial

  2. Postprandial Substrate Oxidation

    Respiratory Exchange Ratio

    Measured: Baseline to 120 minutes postprandial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2025
  2. Study start3 Nov 2024
  3. Primary completion15 Jan 2026
  4. Study completion15 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
3 arm randomized cross-over trial
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07122765
Sponsor's protocol ID
NCR245996
Acronym
MetChrono
Status last verified
Feb 2026
First submitted
7 Aug 2025
Last updated
25 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymized participant data will be shared with researchers upon resonable request and data will be deposited on Open Science Framework

Questions about this trial

What is this clinical trial studying?

A study testing Mixed Meal Feeding Challenge in people with Feeding and Metabolism, run by George Washington University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pulse Wave Analysis (time frame: Baseline to 60 and 120 minutes postprandial). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in